• Adenosine Triphosphate (ATP): Beyond Energy—Precision in Mit

  2026-05-19

  Explore how Adenosine triphosphate (ATP) advances mitochondrial metabolism research beyond its role as an energy carrier. This article uniquely dissects post-translational enzyme control and practical assay decisions, drawing from the latest molecular insights.

• Partial β-Secretase Inhibition Lowers Amyloid β Without Syna

  2026-05-19

  Satir et al. (2020) demonstrate that moderate inhibition of β-secretase (BACE) can reduce amyloid β (Aβ) production by up to 50% without impairing synaptic transmission in cultured neurons. This finding supports strategies targeting partial Aβ reduction for safer Alzheimer's disease intervention, and informs the design of future BACE inhibitor trials.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Protein Re

  2026-05-18

  This study uncovers a noncanonical role for the mitochondrial DNAJC co-chaperone TCAIM, which specifically binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, thereby modulating mitochondrial metabolism. These findings reveal a new post-translational regulatory mechanism impacting the TCA cycle and cellular energy homeostasis, with implications for understanding metabolic control in health and disease.

• N1-Methyl-Pseudouridine-5'-Triphosphate in Inhaled RNA Thera

  2026-05-18

  Explore how N1-Methyl-Pseudouridine-5'-Triphosphate advances inhaled RNA therapeutics and tumor microenvironment modulation. This article delivers a unique, evidence-backed perspective for researchers seeking to optimize mRNA design for lung cancer immunotherapy.

• Epidermal Growth Factor: Applied Workflows and Research Insi

  2026-05-17

  APExBIO’s recombinant human EGF unlocks precision control over cell proliferation, migration, and mucosal healing in experimental models. This guide synthesizes advanced protocols, troubleshooting strategies, and key insights from recent research—empowering labs to design robust, high-impact studies.

• Rottlerin: Selective PKC Inhibitor for Cell Signaling Experi

  2026-05-16

  Rottlerin empowers researchers to selectively inhibit PKCδ, enabling precise dissection of proliferation and apoptosis pathways in cancer and infection models. Its robust, well-characterized profile from APExBIO ensures reproducible results for experimental and translational workflows.

• Hoechst 33258: Precision DNA Staining for Tumor pH-Linked Ce

  2026-05-15

  Explore how Hoechst 33258, a bis-benzimide DNA stain, enables high-fidelity DNA visualization and viability assessment in pH-sensitive tumor research. This article delves into assay optimization and mechanistic insights, offering a unique perspective beyond conventional protocols.

• Anti-Inflammatory, Anti-Angiogenic Airway Stent Halts Trache

  2026-05-15

  Zhao et al. present a novel airway stent that integrates anti-inflammatory and anti-angiogenic strategies to significantly reduce tracheal in-stent restenosis (TISR). Through a combination of advanced materials and targeted drug delivery, the study demonstrates robust efficacy in mitigating excessive vascularization, fibroblast proliferation, and infection, offering a promising translational avenue for airway intervention.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Protein De

  2026-05-14

  Wang et al. (2025) identify TCAIM as a DNAJC-type mitochondrial co-chaperone that specifically binds to a-ketoglutarate dehydrogenase (OGDH), facilitating its post-translational reduction by HSPA9 and LONP1. This mechanism uncovers a novel regulatory axis for mitochondrial metabolism, with significant implications for understanding energy homeostasis and proteostasis in cellular systems.

• Propranolol Modulates Metabolic Pathways to Improve Burn Out

  2026-05-14

  This phase II randomized trial demonstrates that propranolol treatment in severely burned patients significantly normalizes metabolomic and lipidomic signatures, attenuating hypermetabolism and inflammation. The study provides mechanistic insights into propranolol’s action on adipose tissue metabolism, highlighting potential strategies for targeted metabolic intervention in critical care.

• Molidustat (BAY85-3934): Workflow Precision for Renal Anemia

  2026-05-13

  Molidustat (BAY85-3934) empowers renal anemia research through highly selective HIF-PH inhibition, enabling endogenous erythropoietin stimulation with physiological fidelity. This guide details optimized workflows, troubleshooting strategies, and integrates new Septin4-HIF-1α mechanistic insights to elevate translational and discovery outcomes.

• H-89: Advanced cAMP-Dependent Protein Kinase Inhibitor Workf

  2026-05-13

  H-89 enables precise dissection of cAMP signaling for research in osteogenesis, apoptosis, and metabolism. This article unpacks best-practice workflows, recent experimental breakthroughs, and troubleshooting strategies to maximize H-89’s utility as a selective protein kinase A inhibitor.

• (R,S)-Anatabine: Precision Modulation of Amyloid and Inflamm

  2026-05-12

  (R,S)-Anatabine is a potent research compound for Alzheimer's disease models, uniquely targeting both amyloid-beta and NF-κB pathways. This article delivers a deeper mechanistic analysis and practical assay guidance beyond existing reviews.

• Cy5-UTP: Advanced RNA Labeling Workflows & Troubleshooting

  2026-05-12

  Cy5-UTP (Cyanine 5-UTP) enables direct, high-sensitivity RNA probe synthesis for applications like FISH and dual-color arrays, streamlining experimental design and reducing post-transcriptional handling. This article unpacks practical workflows, experimental pitfalls, and optimization strategies, drawing actionable insights from recent advances in RNA nanoparticle chemistry.

• HBsAg Manipulates TBK1 to Suppress Interferon and Trigger Au

  2026-05-11

  This study uncovers how hepatitis B surface antigen (HBsAg) directly interacts with TANK-binding kinase 1 (TBK1) to suppress type I interferon signaling and induce early autophagy. The findings provide mechanistic insight into HBV immune evasion and suggest potential implications for liver disease progression.

674 records 17/45 page Previous Next First page 上5页 1617181920 下5页 Last page